Instructions for Maxotropil (Piracetam) 40 tablets
Brief Description Piracetam
Clinical-pharmacological group: Nootropic drug.
Pharmacotherapy group: Nootropic agent.
Release form and description
The tablets are effervescent white or almost white with indentations, round, flat cylindrical, with a double-sided chamfer, with a characteristic lemon smell; roughness of the surface of the tablet is allowed.
Testimony Piracetam
Memory impairments, dizziness, decreased concentration, emotional lability, dementia due to disorders of cerebral circulation (ischemic stroke), brain injuries, Alzheimer's disease, in old age, intellectual-mnestic disturbances, cortical myoclonia; comatose states of vascular, traumatic or toxic genesis; treatment of withdrawal and psychoorganic syndrome in chronic alcoholism; learning disabilities in children not related to inadequate training or features of family environment (as part of the combined therapy); sickle-cell anaemia (as part of the combined therapy).
Method of use and dosage Maxotropil
Used inwards, in/m or in/w. The dose, method and procedure for the use and duration of the therapy are determined individually, depending on the indications, clinical situation, the patient's age and the dosage form used.
The parenteral administration of piracetam is prescribed when the oral forms (unconscious state, difficulty swallowing) cannot be applied. The preferred method is to introduce.
Pharmacological effect Maxotropil
Nootropic agent Piracetam. It has a positive effect on the metabolic processes and blood circulation of the brain. Improves glucose utilization, improves metabolic processes, improves microcirculation in ischemized areas, inhibits the aggregation of activated platelets. It has a protective effect in cases of brain damage caused by hypoxia, intoxication, electroshock. Improves the integrative activity of the brain. It has no sedative and psychostimulative effects. Reduces the duration of the induced vestibular neuronite. Inhibits the increased aggregation of activated platelets and, in the case of pathological erythrocyte rigidity, improves their deformability and filtration ability.
